📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Escient Pharmaceuticals

1.1 - Company Overview

Escient Pharmaceuticals Logo

Escient Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of bio-technical research and development services focused on advancing first-in-class G Protein-Coupled Receptor targeted drugs and therapies for neuro-immuno-inflammatory and autoreactive diseases. Pipeline includes EP262, an oral, once-daily small molecule MRGPRX2 antagonist for the potential treatment of mast cell-mediated diseases (including chronic urticarias and atopic dermatitis), and EP547, an oral, once-daily MRGPRX4 antagonist for cholestatic and uremic pruritus.

Products and services

  • Bio-technical research and development services: First-in-class effort advancing G Protein-Coupled Receptor-targeted drugs, delivering therapies for neuro-immuno-inflammatory and autoreactive diseases through focused research and development
  • EP262: Small-molecule oral, once-daily antagonist of MRGPRX2 engineered for potential treatment of mast cell-mediated diseases, including chronic urticarias and atopic dermatitis
  • EP547: Small-molecule oral, once-daily antagonist of MRGPRX4 architected for potential treatment of cholestatic pruritus and uremic pruritus

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Escient Pharmaceuticals

ChemoCentryx Logo

ChemoCentryx

HQ: United States Website
  • Description: Provider of orally administered small-molecule therapeutics targeting chemokine and related chemo-attractant receptors for inflammatory and autoimmune diseases and cancer, focusing on the discovery, development and commercialization of new medications.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ChemoCentryx company profile →
Hycor Biomedical Logo

Hycor Biomedical

HQ: United States Website
  • Description: Provider of diagnostic systems and assays for allergy and mast cell activation, including NOVEOS for allergy testing with small sample volumes; NOVEOS assay reagents, consumables, and supplies for specific IgE tests; a Tryptase Assay chemiluminescent microparticle immunoassay for serum tryptase detection; and TASSO+, a capillary blood collection device compatible with NOVEOS.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Hycor Biomedical company profile →
Equillium Logo

Equillium

HQ: United States Website
  • Description: Provider of therapeutics for autoimmune and inflammatory disorders, including itolizumab, a clinical-stage monoclonal antibody targeting the CD6-ALCAM pathway; EQ101, a tri-specific cytokine inhibitor of IL-2/IL-9/IL-15 in Phase 2 for alopecia areata; EQ302, an oral bi-specific inhibitor of IL-15/IL-21 in pre-clinical; and a multi-cytokine platform generating composite peptides to selectively block key cytokines at shared receptors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Equillium company profile →
Graviton Logo

Graviton

HQ: United States Website
  • Description: Provider of clinical-stage biotech therapies, developing selective ROCK2 inhibitors for fibrotic, autoimmune and CNS diseases; a C6 monoclonal antibody for neurodegenerative diseases; and DYRK inhibitors for diabetes, neurological disorders and cancers. Conducts clinical trials and partners with Ovid Therapeutics and Sino Biopharmaceutical for development and commercialization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Graviton company profile →
Deka Biosciences Logo

Deka Biosciences

HQ: United States Website
  • Description: Provider of cytokine therapy platforms, including Diakine™ combining cytokines in a single treatment for cancer and inflammatory diseases; an oncology platform with disease-targeting scaffolds that link cytokines to stimulate the immune system; an anti-inflammatory platform targeting specific tissue markers; precision medicine using genetic tests to personalize Diakines™; and manufacturing via a unique scaffold for higher yields and lower costs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Deka Biosciences company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Escient Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Escient Pharmaceuticals

2.2 - Growth funds investing in similar companies to Escient Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Escient Pharmaceuticals

4.2 - Public trading comparable groups for Escient Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Escient Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Escient Pharmaceuticals

What does Escient Pharmaceuticals do?

Escient Pharmaceuticals is a provider of bio-technical research and development services focused on advancing first-in-class G Protein-Coupled Receptor targeted drugs and therapies for neuro-immuno-inflammatory and autoreactive diseases. Pipeline includes EP262, an oral, once-daily small molecule MRGPRX2 antagonist for the potential treatment of mast cell-mediated diseases (including chronic urticarias and atopic dermatitis), and EP547, an oral, once-daily MRGPRX4 antagonist for cholestatic and uremic pruritus.

Who are Escient Pharmaceuticals's competitors?

Escient Pharmaceuticals's competitors and similar companies include ChemoCentryx, Hycor Biomedical, Equillium, Graviton, and Deka Biosciences.

Where is Escient Pharmaceuticals headquartered?

Escient Pharmaceuticals is headquartered in United States.

How many employees does Escient Pharmaceuticals have?

Escient Pharmaceuticals has 1,000 employees 🔒.

When was Escient Pharmaceuticals founded?

Escient Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Escient Pharmaceuticals in?

Escient Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Escient Pharmaceuticals

Who are the top strategic acquirers in Escient Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Escient Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Escient Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Escient Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Escient Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Escient Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Escient Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Escient Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Escient Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Escient Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Escient Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Escient Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Escient Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Escient Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Escient Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Escient Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Escient Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Escient Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Escient Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Escient Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Escient Pharmaceuticals

Launch login modal Launch register modal